A year into the coronavirus pandemic and now with a vaccine finally approved by the TGA for use in Australia we speak with TSANZ president Professor Bruce Thompson about vaccine rollout and how COVID-19 will continue to affect the field of respiratory medicine. We also talk about TSANZs controversial position on e-cigarettes, the devastating lung condition silicosis and how changing the language we use to talk about respiratory conditions could help make the biggest difference to patient outcomes in 2021.

From off-the-shelf CAR T-cell therapy products, and a big focus on drug-antibody conjugates and novel molecular compound trials to the search for new immunotherapy regimens we talk to HSANZ president Dr Leanne Berkahn about what 2021 will bring to the field of haematology.